NCT00708175 - Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose. | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions

Bone Metabolism

Interventions

DRUG

Pioglitazone

Pioglitazone 30 mg, tablets, orally, once daily for 4 weeks, then increased to Pioglitazone 45 mg, tablets, orally, once daily for up to 48 weeks.

DRUG

Placebo

Pioglitazone placebo-matching tablets, orally, once daily for up to 52 weeks.

Trial Locations (34)

Unknown

Greenbrae

Los Banos

San Diego

Walnut Creek

West Hills

Lakewood

Longmont

Boynton Beach

Hialeah

Jupiter

Dunwoody

Gainesville

Honolulu

Idaho Falls

Chicago

Des Moines

Iowa City

Louisville

Metarie

Scarborough

Bethesda

Detroit

Omaha

Albuquerque

Mineola

West Haverstraw

Pinehurst

Cincinnati

Portland

Aiken

Greenville

Brentwood

Denton

Houston